Table 3.
Prognostic index | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
TCGA SKCM set (n = 92) | ||||
Age | 1.021 (1.003–1.039) | 0.022 | 1.015 (0.995–1.035) | 0.148 |
Gender | 0.837 (0.496–1.411) | 0.504 | ||
Race | 1.102 (0.15–8.089) | 0.924 | ||
Pathological stage | 1.406 (1.023–1.932) | 0.035 | 0.745 (0.43–1.292) | 0.295 |
Pathological M | 47.619 (10.351–219.066) | < 0.001 | 21.963 (4.23–114.032) | < 0.001 |
Pathological N | 1.407 (1.081–1.831) | 0.011 | 1.68 (1.114–2.533) | 0.013 |
Pathological T | 1.319 (1.1–1.582) | 0.003 | 1.324 (1.058–1.658) | 0.014 |
Risk score | 1.699 (1.118–2.582) | 0.013 | 1.351 (1.112–1.631) | 0.027 |
T, tumor; N, lymph node; HR, hazard ratio; CI, confidence intervals